Atogepant for Migraine Prevention: A Systematic Review of Efficacy and Safety.

Alok SinghMahesh Kumar Balasundaram

Published in: Clinical drug investigation (2022)

Atogepant seems to be beneficial for migraine prevention, and it may be of more benefit in individuals who do not wish to take the drug as an injection or do not require a prolonged duration of drug effect. However, head-to-head trials with other CGRP antagonists are required to ascertain its place in migraine prevention.

Keyphrases

optic nerve
emergency department
adverse drug
drug induced